The Mechanism Versus PPI Trial
Part of paid clinical trials in San Deigo, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06999577
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Cough
- Dysphonia
- Laryngopharyngeal Reflux
- Reflux
- Throat Clearing
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Omeprazole 40 MG — DRUG8 week double dose therapy of proton pump inhibitor or placebo.
- Laryngeal Recalibration Therapy — BEHAVIORALLRT utilizes therapies that SLPs standardly utilize (mechanical and cognitive guidance) in combination specifically designed to treat laryngeal symptoms. Each session with the SLP will guide subjects through these therapies. The existing script-based LRT protocol consists of the following: 1) mechanical guidance (laryngeal suppression, voice production, breath coordination), 2) cognitive guidance (identification of thinking patterns, recalibration of thoughts about laryngeal sensations).
- GERD Lifestyle Recommendations — BEHAVIORALThis is the typical lifestyle recommendations for GERD used clinically.
Study Details
The goal of this clinical trial is to learn if a mechanism guided strategy that utilizes a multidisciplinary approach to treat adults patients (age 18-89) with chronic throat symptoms who are undergoing clinical evaluation for laryngopharyngeal reflux (LPR) is more effective than the usual care strategy with proton pump inhibitor (PPI) therapy used in gastroenterology for these patients. The main question it aims to answer is: Will a greater proportion of the mechanism guided strategy participants achieve symptom response in comparison to the usual care strategy participants? If there is a comparison group: Researchers will compare the mechanism guided strategy to usual care strategy to see if treatment response differs between the groups. Participants will be be asked to do the following: * participate in an 8-week blinded study phase where they will be randomized to either 1) Mechanism Guided Strategy or 2) Usual Care Strategy * take an oral capsule daily (omeprazole 40mg or placebo) * come to 3 in-person visits at UC San Diego Health for an intervention visit with a study provider * consider incorporating recommended lifestyle modifications * complete weekly surveys
Key Dates
- Start date
- Jun 4, 2025
- Status verified
- Jul 2025
- Primary completion
- May 1, 2029
- Completion
- Jul 1, 2029
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Mechanism Guided Strategy1\) 8-week course of double dose PPI or placebo; 2) Laryngeal Recalibration Therapy (LRT) with speech language pathologist (SLP). Subjects will receive PPI if their reflux monitoring is consistent with GERD and placebo if it is not consistent with GERD. SLP will administer LRT: LRT utilizes therapies that SLPs standardly utilize (mechanical and cognitive guidance) in combination specifically designed to treat laryngeal symptoms. 1. Mechanical Guidance: The SLP will guide subjects through laryngeal suppression, changing voice production, and improving breath coordination. 2. Cognitive Guidance: The SLP will guide subjects through relaxation and conceptualization changes. 3. Lifestyle Recommendations: In addition to receiving LRT, subjects will be counseled on typical lifestyle recommendations for GERD, detailed in the Usual Care Strategy below.
- Active Comparator: Usual Care Strategy1\) an 8-week course of double dose PPI and 2) lifestyle counseling. This represents the control group receiving usual care and will serve as the study's active control group. In order to maintain group concealment, subjects will receive counseling from a study investigator on standard lifestyle modifications recommended for GERD at intervals mirroring that of the mechanism guided strategy: week 1, week 4, and week 8 which is also reflective of standard recommended follow-up and counseling in GERD management.
Primary Outcome Measure
Symptom Response [ Time Frame: 5 years ]
Central Contacts
- Lorijane Robles858-246-5236
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Diego | San Deigo | California | 92093 |
Find similar trials in San Deigo, CA
Related Studies
- The Johns Hopkins Heartburn Center RegistryEnrolling By Invitation · Johns Hopkins University · Orange, California
- PhoRTE® Therapy Efficacy: In-Person Versus TelehealthNot Yet Recruiting · University of Southern California · Arcadia, California
- Active vs. Passive VR During Office-based ENT ProceduresNot Yet Recruiting · Cedars-Sinai Medical Center · Los Angeles, California
- The Role of Laryngopharyngeal Reflux in IPFRecruiting · National Jewish Health · Denver, Colorado